(Q43181468)

15 November 2017

Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study (English)

1 reference

15 November 2017

0 references

1 reference

1 reference

Toni O Kiljander

1

1 reference

15 November 2017

Ola Junghard

series ordinal

2

1 reference

15 November 2017

Ola Beckman

series ordinal

3

1 reference

15 November 2017

Tore Lind

series ordinal

4

1 reference

15 November 2017

language of work or name

English

0 references

publication date

28 January 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

15 November 2017

1 reference

15 November 2017

181

1 reference

15 November 2017

10

1 reference

15 November 2017

1042-1048

1 reference

Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome

15 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Epidemiology of gastro-oesophageal reflux disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Gastroesophageal reflux: a potential asthma trigger

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

The role of gastroesophageal reflux in chronic cough and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Effects of esomeprazole 40 mg twice daily on asthma: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

The role of proton pump inhibitors in the management of gastroesophageal reflux disease-related asthma and chronic cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Validation of a standardized version of the Asthma Quality of Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Efficacy of esomeprazole for treatment of poorly controlled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

Nonacid reflux in patients with chronic cough on acid-suppressive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200910-1537OC

10.1164/RCCM.200910-1537OC

21 January 2018

Identifiers

DOI

1 reference

15 November 2017

1 reference